JM Financial raised concerns around Mankind Pharma’s recent BSV acquisition, which was executed at a high valuation and is expected to dilute return on capitalJM Financial raised concerns around Mankind Pharma’s recent BSV acquisition, which was executed at a high valuation and is expected to dilute return on capital Latest News [ SOBAN NEWS: International and National ]